Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines

The SARS-CoV-2 pandemic has, as of July 2022, infected more than 550 million people and caused over 6 million deaths across the world. COVID-19 vaccines were quickly developed to protect against severe disease, hospitalization and death. In the present study, we performed a direct comparative analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Hvidt, Astrid K., Baerends, Eva A. M., Søgaard, Ole S., Stærke, Nina B., Raben, Dorthe, Reekie, Joanne, Nielsen, Henrik, Johansen, Isik S., Wiese, Lothar, Benfield, Thomas L., Iversen, Kasper K., Mustafa, Ahmed B., Juhl, Maria R., Petersen, Kristine T., Ostrowski, Sisse R., Lindvig, Susan O., Rasmussen, Line D., Schleimann, Marianne H., Andersen, Sidsel D., Juhl, Anna K., Dietz, Lisa L., Andreasen, Signe R., Lundgren, Jens, Østergaard, Lars, Tolstrup, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574042/
https://www.ncbi.nlm.nih.gov/pubmed/36262278
http://dx.doi.org/10.3389/fmed.2022.994160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574042/
https://www.ncbi.nlm.nih.gov/pubmed/36262278
http://dx.doi.org/10.3389/fmed.2022.994160

Ejemplares similares